These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Validation and ranking of seven staging systems of hepatocellular carcinoma. Chen ZH; Hong YF; Lin J; Li X; Wu DH; Wen JY; Chen J; Ruan DY; Lin Q; Dong M; Wei L; Wang TT; Lin ZX; Ma XK; Wu XY; Xu R Oncol Lett; 2017 Jul; 14(1):705-714. PubMed ID: 28693224 [TBL] [Abstract][Full Text] [Related]
3. Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort. Zhang JF; Shu ZJ; Xie CY; Li Q; Jin XH; Gu W; Jiang FJ; Ling CQ PLoS One; 2014; 9(3):e88182. PubMed ID: 24609114 [TBL] [Abstract][Full Text] [Related]
5. Comparison of staging systems of hepatocellular carcinoma. Sirivatanauksorn Y; Tovikkai C HPB Surg; 2011; 2011():818217. PubMed ID: 21760664 [TBL] [Abstract][Full Text] [Related]
6. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). Kudo M; Chung H; Osaki Y J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442 [TBL] [Abstract][Full Text] [Related]
7. Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population. Chan SL; Mo FK; Johnson PJ; Liem GS; Chan TC; Poon MC; Ma BB; Leung TW; Lai PB; Chan AT; Mok TS; Yeo W J Gastroenterol Hepatol; 2011 Feb; 26(2):340-7. PubMed ID: 21261725 [TBL] [Abstract][Full Text] [Related]
8. Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems. Shao YY; Lu LC; Lin ZZ; Hsu C; Shen YC; Hsu CH; Cheng AL Br J Cancer; 2012 Nov; 107(10):1672-7. PubMed ID: 23059748 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992 [TBL] [Abstract][Full Text] [Related]
10. Advanced hepatocellular carcinoma: which staging systems best predict prognosis? Huitzil-Melendez FD; Capanu M; O'Reilly EM; Duffy A; Gansukh B; Saltz LL; Abou-Alfa GK J Clin Oncol; 2010 Jun; 28(17):2889-95. PubMed ID: 20458042 [TBL] [Abstract][Full Text] [Related]
11. Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma. Kondo K; Chijiiwa K; Nagano M; Hiyoshi M; Kai M; Maehara N; Ohuchida J; Nakao H; Ohkuwa Y Hepatogastroenterology; 2007; 54(77):1534-8. PubMed ID: 17708292 [TBL] [Abstract][Full Text] [Related]
12. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Leung TW; Tang AM; Zee B; Lau WY; Lai PB; Leung KL; Lau JT; Yu SC; Johnson PJ Cancer; 2002 Mar; 94(6):1760-9. PubMed ID: 11920539 [TBL] [Abstract][Full Text] [Related]
13. [Evaluations of seven different clinical staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection]. Zhao J; Yan T; Huang Z; Bi X; Zhao H; Zhou J; Li Z; Li Y; Li C; Cai J Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):903-7. PubMed ID: 24854909 [TBL] [Abstract][Full Text] [Related]
14. Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area. Lee JH; Kim HY; Kim YJ; Yoon JH; Chung JW; Lee HS J Gastroenterol Hepatol; 2015 Apr; 30(4):696-705. PubMed ID: 25250761 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of the Predictive Values of Eight Staging Systems for Primary Liver Cancer in Prognosis of Combined Hepatocellular-cholangiocellular Carcinoma Patients after Surgery]. Li H; Wang XT; Zhang AQ; Meng XF; Yu Q; Lü WP; Duan WD; Dong JH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Apr; 38(2):175-81. PubMed ID: 27181894 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems. Tannus RK; Almeida-Carvalho SR; Loureiro-Matos CA; Miziara-Gonzalez A; Salzedas-Netto AA; Szejnfeld D; D'Ippolito G; Pereira-Lanzoni V; Souza-Silva I PLoS One; 2018; 13(4):e0194922. PubMed ID: 29617435 [TBL] [Abstract][Full Text] [Related]
17. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems. Giannini E; Risso D; Botta F; Romagnoli P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Testa R J Intern Med; 2004 Mar; 255(3):399-408. PubMed ID: 14871465 [TBL] [Abstract][Full Text] [Related]
18. TNM/Okuda/Barcelona/UNOS/CLIP International Multidisciplinary Classification of Hepatocellular Carcinoma: concepts, perspectives, and radiologic implications. Faria SC; Szklaruk J; Kaseb AO; Hassabo HM; Elsayes KM Abdom Imaging; 2014 Oct; 39(5):1070-87. PubMed ID: 24695938 [TBL] [Abstract][Full Text] [Related]
19. Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization. Georgiades CS; Liapi E; Frangakis C; Park JU; Kim HW; Hong K; Geschwind JF J Vasc Interv Radiol; 2006 Oct; 17(10):1619-24. PubMed ID: 17057003 [TBL] [Abstract][Full Text] [Related]
20. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials. Li X; Dong M; Lin Q; Chen ZH; Ma XK; Xing YF; Wan XB; Wen JY; Wei L; Chen J; Wu XY Asia Pac J Clin Oncol; 2013 Mar; 9(1):86-92. PubMed ID: 23279888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]